GLP-1 Weight Maintenance Guide
What Happens When You Stop Ozempic — and How to Keep the Weight Off
The STEP 4 trial is unambiguous: most people regain two-thirds of lost weight within a year of stopping semaglutide. This guide explains the biology of weight regain, maintenance dosing strategies, and how to build the habits that give you the best chance of sustaining results — whether you stay on medication or eventually stop.
Why Weight Regain Happens: The Set Point Biology
The STEP 4 trial was a landmark extension of the STEP 1 semaglutide trial. Patients who had lost an average of 17% of their body weight over 68 weeks on semaglutide were then randomized to either continue semaglutide or switch to placebo. Within one year of stopping, the placebo group had regained approximately two-thirds of their lost weight — about 11.6% of their original body weight, at a rate of roughly 1-2 lbs per month.
This is not a failure of willpower — it is the body defending its weight set point, a phenomenon documented for decades in obesity research. The body has powerful compensatory mechanisms to restore weight after loss: appetite hormones (ghrelin) increase, satiety hormones (leptin, PYY) decrease, metabolic rate slows (adaptive thermogenesis), and the brain's reward circuits increase the motivational salience of food. GLP-1 medications suppress all of these counter-regulatory responses; when the drug stops, they resume in full force.
This biology is increasingly reshaping how physicians think about GLP-1 medications: not as a temporary intervention to use until you lose the weight and then stop, but as a chronic treatment for a chronic condition — exactly as antihypertensives are used for high blood pressure. No one expects to stop their blood pressure medication after their numbers normalize and maintain the benefit without the drug. Obesity is no different from this physiological standpoint.
Maintenance Dosing: Continuing at Full or Reduced Dose
Semaglutide (Ozempic / Wegovy) Maintenance
Wegovy 2.4mg weekly is FDA-approved as a chronic weight management medication with no defined stopping point. Continuing at the full dose maintains the maximum weight loss benefit and the fullest suppression of appetite and weight-regain signals. For patients who have reached their goal weight, some physicians trial a step-down to 1.7mg or 1mg to reduce cost and side effect exposure — weight is monitored closely and dose restored if regain occurs.
Ozempic (prescribed off-label for weight loss at doses up to 2mg) can similarly be continued long-term. The key is that continuous GLP-1 exposure is required to maintain the hormonal environment that supports the lower body weight. There is no “training” of the body to maintain weight on its own — the drug must be present to continuously suppress the compensatory weight-regain drive.
Tirzepatide (Mounjaro / Zepbound) Maintenance
The SURMOUNT-4 trial specifically studied maintenance dosing for tirzepatide. Patients who had lost weight on tirzepatide were randomized to continue at a maintenance dose or switch to placebo. Those who continued tirzepatide (even at doses lower than their maximum) maintained over 80% of their weight loss, while the placebo group regained a large portion. This is the strongest evidence to date that continuing at a lower maintenance dose is a viable long-term strategy.
Zepbound (tirzepatide for weight management) is available at doses from 2.5mg to 15mg weekly. A maintenance dose of 5mg or 7.5mg after reaching goal on 10mg or 15mg may be sufficient for many patients — with cost savings and often better tolerability — while still maintaining meaningful weight loss vs placebo. This should be personalized with your prescriber.
If You Must Stop: Building an Exit Strategy That Works
Sometimes stopping GLP-1 medication is necessary — due to cost, side effects, pregnancy planning, surgery, or personal choice. If you are planning to stop, these strategies give you the best chance of sustaining your results. The goal is to build as much of a metabolic and behavioral buffer as possible before stopping, so the compensatory weight-regain response has less momentum to overcome.
Taper, Do Not Stop Abruptly
Reduce your dose gradually over 3-4 months rather than stopping cold turkey. This gives your appetite regulation systems time to re-establish some equilibrium rather than experiencing a sudden hormonal cliff that dramatically increases hunger and cravings overnight.
Build Muscle Before You Stop
Muscle mass is metabolically active tissue — it raises your basal metabolic rate and creates a buffer against the metabolic slowing (adaptive thermogenesis) that accelerates weight regain after stopping GLP-1s. Start resistance training 3x/week at least 3-4 months before stopping. Aim to add or preserve as much lean mass as possible before the drug is removed.
Lock In Dietary Habits
GLP-1 medications train you to eat less, eat slower, and be satisfied with smaller portions. The months before stopping are the critical window to make these reduced-portion habits automatic. Track your meals, practice consistent meal timing, and cement the protein-priority dietary pattern (1.2g/kg bodyweight) that will be essential for maintaining metabolic rate and satiety without the drug.
Monitor Weight Aggressively After Stopping
Set a personal “action threshold” of +5-10 lbs above your goal weight. If you cross this threshold in the months after stopping, act immediately: return to your prescriber, restart or modify your approach. Early intervention prevents small regain from becoming large regain. Log your weight in Shotlee weekly without judgment — the trend data is what matters, not daily fluctuations.
Dietary and Lifestyle Habits That Actually Stick
Research on long-term weight maintenance consistently identifies the same cluster of behaviors in people who successfully maintain significant weight loss. These are evidence-based priorities for the GLP-1 maintenance phase, whether you are continuing medication or transitioning off it.
Protein Priority
Target 1.2-1.6g of protein per kg bodyweight daily. High protein intake preserves muscle mass, increases satiety, and has the highest thermic effect of feeding (burns more calories to digest). Distribute protein evenly across meals rather than loading it into dinner.
Resistance Training 3x/Week
Strength training is the single most evidence-supported lifestyle intervention for long-term weight maintenance. It builds and preserves metabolically active muscle mass, counters the metabolic slowdown from weight loss, and improves insulin sensitivity — all critical for the post-GLP-1 period.
Mediterranean-Style Diet
The Mediterranean dietary pattern (high in vegetables, legumes, olive oil, fish, and whole grains; low in processed foods and added sugar) is the most robustly evidence-backed dietary approach for long-term weight maintenance and cardiovascular health — benefits that extend and complement GLP-1 therapy.
Consistent Meal Timing
Eating at consistent times supports circadian metabolic regulation, reduces impulsive eating, and makes calorie awareness easier. Many GLP-1 users naturally gravitate toward 2-3 defined meal times rather than grazing — maintaining this structure after stopping the medication is important for sustained satiety.
Frequently Asked Questions
Will I regain weight if I stop Ozempic or Wegovy?
The clinical evidence is clear: most people regain a significant portion of lost weight when they stop GLP-1 medications. The STEP 4 trial showed that patients who stopped semaglutide after 68 weeks regained approximately two-thirds of their lost weight within one year — about 1-2 lbs per month. This is because GLP-1 medications work by continuously lowering the body's defended weight set point; when the drug stops, the hormonal and neural signals driving weight regain resume. This does not mean GLP-1s are a failure — it means they are a chronic treatment for a chronic condition, much like antihypertensives for blood pressure.
What is maintenance dosing for Wegovy or Ozempic?
Maintenance dosing refers to continuing GLP-1 medication at the effective dose (or sometimes a reduced dose) indefinitely to sustain weight loss. The FDA-approved approach is to continue Wegovy at 2.4mg weekly as a long-term treatment. Some physicians use lower maintenance doses (1.7mg or 1mg semaglutide, or lower tirzepatide doses) once the goal weight is reached, which reduces cost and may improve tolerability. SURMOUNT-4 showed that continuing tirzepatide at a lower maintenance dose preserved over 80% of weight loss compared to stopping entirely.
What is the best exit strategy if I want to stop my GLP-1 medication?
If stopping is necessary or desired, the recommended approach is: (1) Do not stop abruptly — taper the dose over 3-4 months to give your appetite regulation time to adjust. (2) Build muscle before stopping — resistance training 3x/week in the months before stopping creates a metabolic buffer against regain. (3) Establish a consistent, sustainable caloric deficit through dietary habits before stopping — the medication has trained you to eat less; try to maintain those habits. (4) Prioritize protein (1.2g/kg bodyweight) to preserve muscle mass. (5) Schedule monthly weigh-ins after stopping and act quickly at early signs of regain rather than waiting for significant regain to occur.